Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-12

Study Completion Date

2020-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will aim to investigate the relation of platelet count (PLT), mean platelet volume (MPV) and platelet distribution width (PDW) with other acute phase reactant c-reactive protein(CRP) in Coronavirus(COVID-19).

As a methodology, patients will be selected in records in one month from the online hospital system. Two groups will be divided before as need for mechanical ventilation or not. The latter comparison will be about three groups as an ambulatory follow-up, hospital follow-up, and intensive care unit follow-up. Parameters will be analyzed according to the groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients

NCT04408378

Coronavirus Infection

UNKNOWN

Study of CRP, Ferritine and D-Dimer in Covid-19 Patients Admitted To Respiratory ICU in Assuit University Hospitals

NCT05102695

Covid19

UNKNOWN

Early Platelet Indices as Biomarkers of Deep Vein Thrombosis and Prognostic Markers in Mechanically Ventilated ICU Patients

NCT07197333

Platelet Distribution Width Mean Platelet Volume

NOT_YET_RECRUITING

Effectiveness of Convalescent Immune Plasma Therapy

NCT04442958

Acute Respiratory Distress Syndrome

COMPLETED NA

Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.

NCT04479280

Coagulation Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, as a methodology, patients diagnosed with PCR test through the online system created for COVID-19 patients will be included in the study. These patients will be divided into 3 groups as outpatient follow-up, hospital follow-up and follow-up with a mechanical ventilator in intensive care. In addition, patients who have completed the 14-day treatment period, which is considered as the turning point time of the world health organization by looking at the patients 3 times, every 5-7 days, which is the accepted incubation period, will be included in the study. In these patients, hemoglobin, leukocyte, platelet, MPV, PDW and CRP values will be examined for 3 weekly measurements. Changes in COVID-19 disease follow-up and treatment of MPV and PDW values, which have not been studied so far, will be investigated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19 Mean Platelet Volume Platelet Destruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ambulatory follow-up

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

Intervention Type DIAGNOSTIC_TEST

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

hospital follow-up

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

Intervention Type DIAGNOSTIC_TEST

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

intensive care unit follow-up

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

Intervention Type DIAGNOSTIC_TEST

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with COVID-19, both PCR tests and computed tomography, as well as control hemogram and CRP tests at one week intervals will be included.

Exclusion Criteria

* Those with suspicion of COVID-19, those who do not perform hemogram and c-reactive protein tests 3 times with one week intervals, those who do not have standard drug treatment will be excluded from the study.

Eligible Sex

ALL

Accepts Healthy Volunteers

No